Heart transplantation has become the accepted treatment for advanced heart failure, with
over 4000–5000 performed in the world annually. Although the number of yearly transplants …

Primary graft failure (PGF) is a devastating complication that occurs in the immediate
postoperative period following heart transplantation. It manifests as severe ventricular …

Although primary graft dysfunction (PGD) is fairly common early after cardiac transplant,
standardized schemes for diagnosis and treatment remain contentious. Most major cardiac …

Vaccines are undoubtedly a powerful weapon in our fight against global pandemics, as
demonstrated in the recent COVID-19 case, yet they often face significant challenges in …

Mesenchymal stem cells (MSC) are capable of differentiating into bone, fat, cartilage, tendon
and other organ progenitor cells. Despite the abundance of MSC within the organism, little is …

Changes in heart transplantation (HT) donor and recipient demographics may influence the
incidence of primary graft dysfunction (PGD). We conducted a retrospective study to …

The shortage of donors in cardiac transplantation may be alleviated by the use of allografts
from donation after circulatory death (DCD) donors. We have previously shown that hearts …

Optimizing kidney preservation is a primary issue in transplantation, particularly in relation to
new donor sources, such as expanded criteria donors (ECDs) and donation after cardiac …

The methods of donor heart preservation are aimed at minimizing graft dysfunction caused
by ischaemia–reperfusion injury (IRI) which inevitably occurs during the ex vivo transport …

BACKGROUND: Successful extremity transplantations and replantations have to be
performed within 6 h of amputation to avoid irreversible tissue loss. This study investigates …